Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Blincyto
Generic name : Blinatumomab
Manufactured By : Amgen
Indications : Relapsed or Refractory B-Cell precursor ALL
Medicine Description : Blincyto is a bispecific T-cell engager (BiTE) therapy for B-cell acute lymphoblastic leukemia (B-ALL). It activates T-cells to attack cancer cells expressing CD19. Given as a continuous IV infusion, it significantly improves remission rates. Side effects include cytokine release syndrome (CRS), neurotoxicity, and fever. Careful monitoring is essential to manage severe immune-related reactions.
Blincyto Medicine (Blinatumomab) is a prescription drug used to treat certain types of acute lymphoblastic leukemia (ALL), a cancer of the blood and bone marrow.
Blincyto is an immunotherapy that works by helping the immune system attack cancer cells. It binds to both T-cells and leukemia cells, enabling the body's immune system to destroy the cancer.
Blincyto is prescribed for adults and children with B-cell precursor acute lymphoblastic leukemia (B-ALL), including those in remission with minimal residual disease (MRD) or those with relapsed or refractory disease.
Blincyto is given as a continuous intravenous (IV) infusion over several days or weeks, as prescribed by a doctor.
Common side effects of Blincyto include fever, headache, nausea, fatigue, infusion-related reactions, and low blood cell counts.
Yes, Blincyto may cause severe side effects such as neurological problems, cytokine release syndrome (CRS), infections, and liver issues. Immediate medical attention is required for severe symptoms.
Blincyto is given in treatment cycles, and the duration depends on the patient's response. Your doctor will determine the length of treatment.
It is best to avoid alcohol while taking Blincyto, as it may worsen liver-related side effects and interfere with treatment.
No, Blincyto may harm an unborn baby. Women should use effective contraception while taking this medication and consult a doctor before pregnancy.
Yes, Blincyto may interact with other drugs, including immunosuppressants and certain antibiotics. Inform your doctor of all medications you take.
Since Blincyto is given as a continuous IV infusion, missed doses should be discussed with your healthcare provider immediately.
Blincyto is administered via IV infusion, so food intake does not directly affect its administration. However, maintaining a balanced diet is recommended.
Monitor for signs of infection, avoid activities that may increase the risk of bleeding or injury, and follow your doctor’s guidance on treatment safety.
Blincyto should be stored in the refrigerator at 2°C to 8°C (36°F to 46°F) and protected from light. Do not freeze.
Blincyto is available by prescription at specialty pharmacies and hospitals. Consult your doctor for guidance on obtaining the medication. Pharma Five assists in its procurement.